(Q41870090)

13 October 2017

Interleukin-1 production by immunologically hyporeactive tumour-bearing mice (English)

1 reference

13 October 2017

Holán V

1

1 reference

13 October 2017

Lipoldová M

series ordinal

2

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 May 1990

1 reference

British Journal of Cancer

13 October 2017

1 reference

13 October 2017

61

1 reference

13 October 2017

5

1 reference

13 October 2017

667-670

1 reference

Cloning and expression of murine interleukin-1 cDNA in Escherichia coli

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Regulation of the immune response by prostaglandins

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Recombinant murine interleukin-1 alpha enhancement of nonspecific antibacterial resistance

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Induction of murine interleukin 1: stimuli and responsive primary cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Interleukin-1 and tumor necrosis factor production by tumor-associated mononuclear leukocytes and peripheral mononuclear leukocytes in cancer patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Anti-tumour efficacy of IL-1 and IL-2.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Down-regulation of the antitumor immune response.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Interleukin 1: an immunological perspective

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Human interleukin 1 is a cytocidal factor for several tumor cell lines.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Analysis of T-cell receptor usage in activated T-cell clones from Hashimoto's thyroiditis and Graves' disease.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Establishment and characterization of a permanent T-cell line producing an antigen non-specific suppressor factor.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971620

Preparation of goat antibodies against interleukin 1: use of an immunoadsorbent to purify interleukin 1

18 August 2018

1 reference

12 December 2020

Endotoxin-induced in vitro release of interleukin-1 by cancer patients' monocytes: relation to stage of disease

1 reference

12 December 2020

Defective interleukin-1 production by monocytes from patients with malignant disease. Interferon increases IL-1 production

1 reference

12 December 2020

Monocyte and lymphocyte interaction in patients with advanced cancer. Evidence for deficient IL-1 production

1 reference

12 December 2020

Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells

1 reference

12 December 2020

Lymphocyte-activating and growth-inhibitory activities for several sources of native and recombinant interleukin 1

1 reference

12 December 2020

Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors

1 reference

12 December 2020

Augmented antitumor effect of recombinant human interleukin-1 alpha by indomethacin

1 reference

12 December 2020

Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models

1 reference

12 December 2020

Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors

1 reference

12 December 2020

Impairment of monocyte functions in advanced head and neck cancer

1 reference

12 December 2020

Decreased interleukin-1 production in aplastic anemia

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.151

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

2337505

1 reference